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Hypotension following obstetric spinal anaesthesia remains a com­
mon and important problem. Recent advances, including better inci­
dence delineation,[1] improved understanding of haemodynamics[2,3] 
and growing clarity on vasopressor choice,[4] have brought us closer 
to the recipe for the perfect obstetric spinal anaesthetic – the elusive 
‘Holy Grail’.[5] Unfortunately, in many resource­limited environments 
these advances have not been adopted. This may be related to con­
cerns about generalisability, in part due to known anatomical and 
physiological differences in populations and minor differences in the 
studied recipes, and in part to the context in which they are applied. 
Research advances have not been translated into practical guidelines 
able to reduce the unacceptable number of fatalities that occur in 
resource­limited environments. In South Africa (SA) the 2011 ­ 2013 
National Committee for Confidential Enquiry into Maternal Deaths 
(NCCEMD)[6] reported that more than half of all anaesthetic deaths 
were still related to spinal hypotension. A gap exists between the 
‘perfect recipe’, developed from a clinical context rooted in resource­
rich research environments, and its application and performance in 
real­world resource­poor environments – conditions experienced by 
more than 75% of the world’s population.[7] This review attempts to 
define this knowledge gap and proposes a research agenda to address 
the deficiencies.
Context is king – the importance of  
the clinical environment
Why is it necessary to distinguish between differing clinical contexts? 
There are marked differences in the availability of staff, equipment, 
drugs and infrastructure across different levels of the health sector. 
This is tacitly acknowledged by the reluctance to implement some 
research findings in resource­poor environments. Management 
strategies need to be adapted to match available clinical skill, drug 
availability, monitoring capabilities and patient profile. To frame 
further discussion, we propose a classification of three contexts that 
potentially require different clinical approaches (Table 1).
Resource­poor clinical contexts are limited on multiple fronts. 
For example, poorer staffing ratios are compounded by a lack of 
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Table 1. Suggested definitions of clinical context in obstetric anaesthesia
Clinical context Personnel Equipment Health system
Resource rich Dedicated senior anaesthetist 
with obstetric expertise
Invasive monitoring, full anaesthetic 
facilities and infusion pumps
Well­assessed and triaged, hydrated and optimised patients. 
Modern theatres, recovery facilities and good staffing ratios
Resource 
constrained
Dedicated junior anaesthetist, 
lacks experience, slower 
reaction times
Basic monitoring (NIBP/ECG/SpO2) in 
all cases, anaesthesia machine, infusion 
pumps usually available
Intermittent­level care – may be dehydrated patients, 
unrecognised comorbidity. Overloaded systems with delays 
in accessing theatres
Resource poor Part­timer/nurse, lack of 
experience, slower reaction 
times, divided attention
NIBP, SPO2 in most cases, Ambu bag and 
oxygen available. No infusion pumps. 
Inconsistent drug and sundry supply
Not reliably assessed and managed preoperatively. 
Undetected pathology more likely. Poor theatre design and 
no recovery facility
NIBP = non­invasive blood pressure; ECG = electrocardiogram; SpO2 = peripheral capillary oxygen saturation. 
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expertise and training. The responsible doctor does not necessarily 
have an understanding of the principles of anaesthesia, and the job 
is often allocated by default to the doctor or nurse who is unable 
to perform the surgery. This is further complicated by a lack of 
available equipment (such as electrocardiographic monitoring) 
and inconsistent drug supplies. Vasopressor choice is often 
dictated by availability rather than preference. In addition, the 
attending doctor is frequently required to perform more than 
one function, often as both obstetrician and anaesthetist, and will 
be making rapid assessments of patients in multiple locations in 
the lead­up to surgery. This increases the likelihood of missing 
significant obstetric and medical comorbidities and significant 
dehydration in patients presenting to theatre. Attending doctors 
may need to administer the initial anaesthetic and also conduct 
the surgery, being required to monitor the anaesthetic either 
directly while operating or via a nurse. This scenario applied 
in 7% of the anaesthetic deaths analysed in a recent national 
report.[8] The anaesthetist may have very limited experience of 
general anaesthesia for caesarean section (CS) and therefore 
inappropriately administer spinal anaesthesia in cases where 
general anaesthesia is indicated. Management strategies must 
therefore be tailored to a low­expertise environment with poorly 
prepared patients and a lack of anaesthetic vigilance. Theoretically, 
simple preventive strategies such as fixed, low­dose vasopressor 
infusions may minimise the need for rapid clinician intervention 
and therefore hold an advantage over strategies highly reliant on 
clinician intervention.
The SA context
The SA health system includes hospitals from all three contexts. 
Tertiary hospitals are often well staffed and well equipped, 
while district­level hospitals, especially in the rural setting, 
suffer from staffing and equipment deficiencies. Even at regional 
level, the number of CSs performed outstrips the number of 
trained anaesthesia providers, creating a relatively resource­
constrained environment. [6] In the Saving Mothers report for 
2011 ­ 2013,[6] three out of every four mothers who died as a 
result of direct anaesthetic causes received spinal anaesthesia, 
with ‘small district hospitals contributing disproportionately to 
anaesthetic related maternal deaths’. This pattern is unusual, as 
mortality rates generally tend to increase in more specialised 
centres owing to greater case complexity. In SA this pattern is 
reversed, with 56% of all deaths occurring in district hospitals, 
35% in the regional centres and 8% in the tertiary centres. [6] The 
majority of women who died in district­level hospitals received 
a spinal anaesthetic. This pattern has been noted in previous 
reports,[8] where 64% of all spinal deaths were related to severe 
uncorrected hypotension. Although the exact case fatality rate for 
spinal v. general anaesthesia is unknown because denominator 
data are incomplete, the total number of anaesthetic deaths in 
SA is increasing, particularly in the group who receive spinal 
anaesthesia. [6] This represents an area where relatively simple 
interventions may result in significant changes.
The clinical context and current 
obstetric evidence
Research on obstetric spinal hypotension has largely been 
performed under highly standardised research conditions, which 
do not reflect the broader SA context. There is an intense focus 
on management of patients by senior clinicians, usually in 
elective rather than emergency cases and often incorporating 
highly specialised invasive monitoring. This is a requirement 
for high­quality research, where sophisticated methods elucidate 
an underlying mechanism and are then translated into simple 
clinical interventions. However, given that these interventions 
will be applied in a significantly different context, they must still 
be tested in the real­world setting. While SA has continued to 
produce internationally recognised research, a gap exists between 
the research context and the reality of the SA public health sector. 
There is a need to translate critical research into pragmatic 
management strategies that target a specific clinical context, and 
then test these strategies in that environment.
Relevant current literature
Over the past 10 years, significant progress has been made in defining 
and predicting hypotension, and describing haemodynamic changes 
during spinal anaesthesia for CS. These insights have all contributed 
to the development of the current state­of­the­art recipe. We will 
discuss each of these aspects in turn, focusing on clinical context 
gaps.
Incidence and definition
The incidence of obstetric spinal hypotension varies according 
to the definition applied.[1] Klohr et al.[1] found across 63 publi­
cations that the incidence of spinal hypotension was 27% when 
defined as a systolic blood pressure (SBP) <70% of baseline, but 
that it increased to 39% using an SBP of <75% of baseline. Up 
to 80% of spinal anaesthetics in obstetrics require the use of a 
vasopressor to treat hypotension.[9] Most of these studies came 
from resource­rich environments, and there are few studies that 
look at this incidence in resource­constrained environments. 
It is reasonable to assume that the incidence and severity of 
hypotension could be significantly higher in the latter setting. 
This is important because the NCCEMD process does not 
address the ‘near­misses’, and therefore does not quantify the 
true extent of the problem.
Prediction of obstetric spinal hypotension
Avoiding spinal hypotension is important for maternal and fetal 
safety as well as for maternal comfort, since even minor degrees 
of hypotension are associated with an increased incidence 
of intraoperative nausea and vomiting.[10] The prediction of 
obstetric spinal hypotension has received considerable attention 
and has recently been the subject of review in a local journal.[11] 
While a number of practical predictors such as body mass index, 
maternal age and baseline heart rate have shown potential, 
results have been conflicting and applied predominantly to 
elective patients. Autonomic indices such as heart rate variability 
have also shown promise,[12] but have yet to be translated 
into a practical clinical tool. Given the high incidence of 
hypotension,[1,9] research in this area should focus on predicting 
which patients will have severe hypotension, where outcomes 
relating to maternal and fetal safety are more likely to be 
affected. We need simple clinical parameters that identify high­
risk patients and can be coupled to preventive strategies or 
earlier referral to specialist centres. There are no scoring systems 
in daily use addressing this need.
Haemodynamic changes under spinal anaesthesia
The dominant mechanism behind obstetric spinal hypotension is a 
reduction in arterial sympathetic tone,[2,3,13,14] although venodilatation 
probably also plays a role. This hypotension results in an increased 
heart rate,[3] although a small proportion of patients may respond 
with hypotension and bradycardia.[15] Better understanding of the 
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mechanism of hypotension has led to clinical management moving 
from a fluid­based strategy towards a vasopressor­based prophylactic 
strategy supported by fluid co­loading.[16] One study proposed that 
heart rate may be ‘the best surrogate indicator of cardiac output 
during spinal anesthesia for cesarean delivery’.[2] This is of particular 
relevance to the resource­poor setting, where targeting simple 
surrogate outcomes such as heart rate could be explored for practical 
implementation in clinical guidelines.
The choice of vasopressor
In recent years there has been a move towards using phenylephrine 
as the agent of choice in treating obstetric spinal hypotension.[4] 
Despite prevailing evidence, practice has been slow to change even 
in settings with similar resources to those in which the research 
was conducted. [17] In an excellent editorial, Smiley[17] questioned 
the reluctance of anaesthetists to embrace the use of phenylephrine 
and offered several explanations for this. One reason put forward 
was that the choice is not perceived as ‘being quite a life and death 
issue’. This argument could be advanced in resource­rich settings 
where a dedicated anaesthetist is available to respond quickly 
and appropriately to a decrease in blood pressure, but it may not 
apply to a less ideal context. Experienced anaesthetists potentially 
respond more rapidly to signals such as patient symptoms and 
heart rate, but this cannot be relied upon in settings where there 
is no dedicated anaesthetist. Preventive strategies that reduce the 
need for rapid intervention should have important advantages 
in this context. Prophylactic strategies have not been adopted in 
SA because of concerns about feasibility in resource­constrained 
hospitals and about safety in the hands of inexperienced clinical staff, 
a concern echoed in international guidelines.[18] This concern may be 
unfounded, given that simple strategies such as fixed­rate, low­dose 
phenylephrine infusions have a low complication rate and provide 
improved haemodynamic stability and are therefore particularly 
suited to the inexperienced anaesthetist. Also, it is only by effective 
prophylactic use of vasopressors that maternal symptoms due to 
spinal hypotension can be prevented.
Vasopressor management strategies
Modern strategies for combating obstetric spinal hypotension 
employ a combination of fluid and a vasopressor. The recommended 
first­line agent is phenylephrine,[4] with the notable exceptions being 
the patient who responds to spinal anaesthesia with bradycardia and 
hypotension, or has undiagnosed cardiac disease and unexpectedly 
requires positive inotropy. Recent literature has moved the debate 
from the choice between ephedrine and phenylephrine to the 
manner in which phenylephrine should be given. This reflects an 
acceptance of phenylephrine as the drug of choice. Initial work using 
high phenylephrine infusion rates (100 µg/min) and aggressive fluid 
co­loading showed that hypotension could be almost eliminated, 
but at the cost of reactive hypertension.[10,19] Subsequent work 
with lower­dose phenylephrine infusions supported prophylactic 
infusions as part of routine CS.[14] Further dose­finding studies 
suggested that a range of 25 ­ 50 µg/min seemed to give the most 
benefit with the fewest side­effects.[20,21] Haemodynamic studies also 
suggested that targeting the baseline heart rate may be the best way 
to maintain cardiac output during phenylephrine administration.[2]
A recent systematic review concluded that prophylactic phenyl­
ephrine infusions reduced maternal hypotension, nausea and 
vomi ting without altering other relevant maternal or neonatal 
outcomes. [22] The setting of this work is elective CS in healthy 
patients, in ideal clinical conditions. In a recent editorial, Butwick 
et al.[16] noted that the potential impact of phenylephrine infusions 
in a number of higher­risk groups, including women undergoing 
unplanned CS, has not been well elucidated. They went on to 
state that ‘titrated phenylephrine infusions co­administered with 
crystalloid should now be recommended for prophylaxis against 
spinal hypotension’.[16] However, because the context of the research 
is very specific, it is not clear how to implement this in differing 
environments.
Current guidelines
Strategies to combat hypotension on a pharmacological basis can be 
divided into ‘reactive’ or ‘preventive’ approaches. Reactive approaches 
generally involve early and aggressive treatment with fluid and a vaso­
pressor bolus in response to a significant decrease in blood pressure. 
Implicit in these strategies is a vigilant anaesthetist with adequate 
experience in the field. Many guidelines offer the choice of ephedrine 
or phenylephrine as the vasopressor, including the National Institute 
for Health and Care Excellence (NICE)[23] and SA guidelines.[24] These 
recommendations reflect caution in applying conclusions drawn 
from research on elective CS in healthy women to the urgent CS in 
women with comorbidity in different clinical environments.
The NICE clinical guidelines for CS[23] state that ‘Women who 
are having a CS under regional anaesthesia should be offered 
intravenous ephedrine or phenylephrine, and volume pre­loading 
with crystalloid or colloid to reduce the risk of hypotension occurring 
during CS.’ They further recommend that ‘intravenous ephedrine or 
phenylephrine should be used in the management of hypotension 
during CS’. One guideline in the UK recommends that anaesthetists 
should ‘only consider phenylephrine infusion for elective CS and 
if they have received training in equipment and the technique’. 
For emergency cases, a bolus technique is recommended.[18] 2004 
SA recommendations[24] state that ‘the standard first line and very 
safe vasopressor is ephedrine’, although later Essential Steps in 
the Management of Obstetric Emergencies (ESMOE) informal 
recommendations allow for either ephedrine or phenylephrine to 
be used. No mention is made of prophylactic vasopressor infusions. 
It is evident that despite overwhelming evidence for the benefit of 
prophylactic phenylephrine infusions in elective patients, clinicians 
are reluctant to implement these findings even in the resource­rich 
setting in which the research was performed. This was highlighted 
more than 6 years ago, but continues to be a concern.[17]
Closing the gap
It is clear that there is a gap between the research clinical context 
and the application of research to the resource­poor context. In 
order to close this gap, we need to develop and test models in a 
broader context and acknowledge the need for context­sensitive 
management strategies. Table 2 offers some hypothetical context­
sensitive guidelines and the rationale for these approaches.
These recipes need to be refined and tested with pragmatic 
studies that evaluate the ability of institutions in differing contexts 
to achieve success with differing guidelines in resource­limited 
areas, by conducting well­designed, multicentre studies. In SA this 
could be accomplished through the establishment of an obstetric 
anaesthesia research group focused on large pragmatic clinical trials 
aimed at improving maternal safety during CS. Such a network could 
be established rapidly by making use of existing structures such as 
the South African Obstetric Anaesthesia Special Interest Society, 
the ESMOE and the South African Perioperative Research Group. 
This network should set national priorities for obstetric anaesthesia 
research and focus on the SA context. Research centres could be 
established in resource­limited areas, where potential interventions 
could be tested in small pilot trials preceding large national pragmatic 
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trials. A proposed research agenda for such a programme is outlined 
in Table 3.
Conclusion
In recent years there have been significant advances in the field 
of obstetric anaesthesia. High­quality research has outlined the 
mechanism, described the haemodynamic changes and refined 
the management of obstetric spinal hypotension. However, there 
is a gap between this knowledge base and its implementation in 
real­world settings outside the research environment. We need to 
acknowledge this gap, and focus on contextualising research findings 
in a pragmatic fashion. This is best achieved through innovative, 
collaborative research, starting in academic centres, and applying the 
findings in the context of limited­resource environments.
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Table 3. Proposed perioperative research agenda for obstetric spinal hypotension
Need Rationale
Validate traditional predictors of spinal hypotension in context and continue to 
explore novel predictors with practical applicability
Early identification of high­risk patients a priority, 
enabling appropriate resource allocation via referral and 
potentially different management strategiesDevelop a robust scoring system to identify mothers at risk of hypotension following 
spinal anaesthesia for CS, using these predictors
Develop easily available novel scoring tools (such as the obstetrics shock index)
Comparison of a prophylactic vasopressor infusion with a treatment bolus strategy 
for the management of hypotension following spinal anaesthesia for CS
Safe practical ways to utilise the current knowledge base in 
resource­poor settings should be tested
Develop simple methods of applying prophylactic vasopressor infusion strategies in 
resource­poor environments
Research the principle of targeting heart rate for the prevention and treatment of 
hypotension: initially in the academic setting, and then apply to regional centres
Newer techniques first studied in controlled, strictly 
protocol­driven studies before testing in other contexts
Develop an obstetric research network in SA and agree on a research framework and 
pathway
Co­ordinating research will enable bigger, multicentre trials, 
while drawing on experience from established centres
Table 2. Suggested vasopressor recipes based on clinical context
Context Presumption Fluids Vasopressor Notes
Resource 
rich
Patients hydrated and well 
assessed, vigilant senior 
anaesthetist
Co­load Phenylephrine infusion (start at 50 µg/
min), titrate to effect
Good evidence­based research 
Target near­normal baseline heart 
rate and blood pressure
Resource 
constrained
May be fluid deficit, 
unrecognised pathology, 
junior anaesthetist
Consider preload, 
administer 
co­load
Phenylephrine infusion (25 µg/min)
Titrate if experienced, otherwise run 
at fixed rate: bolus intermittently and 
discontinue if reactive hypertension
Applied from research­setting data 
Good theoretical basis, requires 
testing in real­world setting
Resource 
poor
May be fluid deficit and 
unrecognised pathology, junior 
anaesthetist, divided attention
Preload/
rehydrate and 
co­load
Phenylephrine (500 µg) or ephedrine 
(50 mg) in first litre of crystalloid – run 
freely then convert to bolus strategy
Lack of evidence for this approach 
Requires study prior to application
